查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1370917

组织学与细胞学市场 - 2018-2028 年全球产业规模、份额、趋势、机会与预测，按检查类型、按产品、按应用、按地区、按竞争细分

Histology and Cytology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type of Examination, By Product, By Application, By Region, By Competition
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022年全球组织学和细胞学市场估值达到157.4亿美元，预计将以14.67%的复合年增长率（CAGR）强劲增长，预计到2028年将达到311.6亿美元。细胞学和组织学是生命科学，专注于生物体中细胞、组织及其微观解剖结构、功能和理解。这些领域有助于理解动植物组织和细胞，特别是在微观层面上，有助于各种应用。

主要市场驱动因素

癌症盛行率增加

市场概况
预测期 2024-2028
2022 年市场规模 157.4亿美元
2028 年市场规模 311.6亿美元
2023-2028 年复合年增长率 12.15%
成长最快的细分市场 细胞学
最大的市场 北美洲

癌症盛行率的上升极大地影响了全球组织学和细胞学市场的成长。组织学和细胞学在诊断癌症和在细胞层面上了解各种疾病方面发挥着至关重要的作用。随着癌症病例数量的增加，对准确诊断技术的需求变得至关重要。这些技术透过在显微镜下检查组织样本和细胞来帮助诊断不同类型的癌症。随着癌症筛检和诊断的增加，对组织学和细胞学服务和设备的需求也随之增加。

不断增加的研发活动

研究与开发 (R&D) 努力推动组织学和细胞学创新，提高诊断和研究过程的准确性和可靠性。透过研发开发的先进成像技术、自动化解决方案和数位病理系统透过提供改进的诊断能力来促进市场成长。研发活动的重点是提高诊断准确性并开发新的染色方法、分子标记和成像技术，从而实现更准确的诊断并推动对这些服务的需求。

专注个人化医疗

在个人化医疗的背景下，对组织学和细胞学服务的需求增加，个人化医疗依赖分子诊断来分析遗传和分子资讯。这些技术有助于识别特定的基因突变和改变，指导治疗决策并促进市场成长。组织学和细胞学为根据患者独特的疾病特征制定治疗策略提供了重要讯息，从而推动了对这些技术的需求。

主要市场挑战

技术复杂性与成本

先进的组织学和细胞学技术通常需要在设备、软体和培训方面进行大量投资，这可能会为资源有限的机构带来障碍。维护成本和与现有系统的整合挑战也会阻碍技术的采用。

实验室劳动力短缺

熟练的实验室专业人员的短缺可能会导致诊断和报告测试结果的延迟，从而影响患者护理和创新。劳动力短缺可能会限制研究、开发和新技术采用的能力。

主要市场趋势

液体活检和循环生物标记

分析体液中生物标记的液体活检的出现增加了对组织学和细胞学服务的需求。这些活检可以实现早期疾病检测，并需要透过传统的组织学和细胞学方法进行验证。

多组学方法

在多个层面研究疾病的多组学方法同时增强了对组织学和细胞学的需求。这些技术提供了对疾病机制的全面见解，组织学和细胞学验证了多组学资料的发现。

细分市场洞察

考试类型

由于其在早期疾病检测中的作用，细胞学领域预计将大幅成长。巴氏抹片和细针穿刺等技术有助于识别异常的细胞变化，从而及时进行干预并改善患者的治疗结果。

应用

药物发现和设计领域占据市场主导地位，因为组织学和细胞学对于验证药物标靶、评估药物安全性和实现个人化医疗至关重要。这些技术提供了对分子相互作用和组织特异性效应的见解。

区域洞察

北美因其先进的医疗保健系统、研究机构和监管框架而引领市场。研究工作的集中和明确的监管环境鼓励创新和技术的采用，推动市场成长。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球组织学与细胞学市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按检查类型（组织学、细胞学）
    • 依产品（仪器和分析软体系统、耗材和试剂）
    • 按应用（药物发现与设计、临床诊断、研究）
    • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
    • 按公司划分 (2022)
  • 市场地图
    • 按考试类型
    • 按产品分类
    • 按应用
    • 按地区

第 6 章：北美组织学与细胞学市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按检查类型（组织学、细胞学）
    • 依产品（仪器和分析软体系统、耗材和试剂）
    • 按应用（药物发现与设计、临床诊断、研究）
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲组织学与细胞学市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按检查类型（组织学、细胞学）
    • 依产品（仪器和分析软体系统、耗材和试剂）
    • 按应用（药物发现与设计、临床诊断、研究）
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第 8 章：亚太地区组织学与细胞学市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按检查类型（组织学、细胞学）
    • 依产品（仪器和分析软体系统、耗材和试剂）
    • 按应用（药物发现与设计、临床诊断、研究）
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第 9 章：南美洲组织学与细胞学市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按检查类型（组织学、细胞学）
    • 依产品（仪器和分析软体系统、耗材和试剂）
    • 按应用（药物发现与设计、临床诊断、研究）
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲组织学和细胞学市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按检查类型（组织学、细胞学）
    • 依产品（仪器和分析软体系统、耗材和试剂）
    • 按应用（药物发现与设计、临床诊断、研究）
    • 按国家/地区
  • MEA：国家分析
    • 南非组织学和细胞学
    • 沙乌地阿拉伯组织学和细胞学
    • 阿联酋组织学和细胞学

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：全球组织学与细胞学市场：SWOT 分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 产品供应
  • 最近的发展
  • 财务（据报导）
  • 主要人员
  • SWOT分析
    • Hologic, Inc.
    • F Hoffmann-La Roche AG.
    • Abbott Laboratories Inc.
    • Becton Dickinson & Co.
    • Danaher Corporation.
    • Merck KGaA.
    • Thermo Fisher Scientific, Inc.
    • Sysmex Corporation.
    • Trivitron Healthcare.
    • Koninklijke Philips NV

第 16 章：策略建议

简介目录
Product Code: 15913

The Global Histology and Cytology Market reached a valuation of USD 15.74 billion in 2022 and is expected to experience robust growth with a Compound Annual Growth Rate (CAGR) of 14.67% and expected to reach USD 31.16 Billion by 2028. Cytology and histology are branches of life science that focus on the structure, function, and understanding of cells, tissues, and their microscopic anatomy in living organisms. These fields contribute to the comprehension of animal and plant tissues and cells, particularly at the microscopic level, aiding in various applications.

Key Market Drivers

Increase in Cancer Prevalence

Market Overview
Forecast Period2024-2028
Market Size 2022USD 15.74 Billion
Market Size 2028USD 31.16 Billion
CAGR 2023-202812.15%
Fastest Growing SegmentCytology
Largest MarketNorth America

The rising prevalence of cancer significantly impacts the growth of the Global Histology and Cytology Market. Histology and cytology play a crucial role in diagnosing cancer and understanding various diseases at the cellular level. With the increasing number of cancer cases, the demand for accurate diagnostic techniques becomes vital. These techniques assist in diagnosing different types of cancers by examining tissue samples and cells under a microscope. As cancer screening and diagnostics increase, the demand for histology and cytology services and equipment also rises.

Growing Research and Development Activities

Research and development (R&D) efforts drive innovation in histology and cytology, enhancing the accuracy and reliability of diagnostic and research processes. Advanced imaging techniques, automation solutions, and digital pathology systems developed through R&D contribute to the market growth by offering improved diagnostic capabilities. R&D activities focus on improving diagnostic accuracy and developing new staining methods, molecular markers, and imaging technologies, which lead to more accurate diagnoses and drive demand for these services.

Focus on Personalized Medicine

The demand for histology and cytology services increases in the context of personalized medicine, which relies on molecular diagnostics to analyze genetic and molecular information. These techniques aid in identifying specific genetic mutations and alterations, guiding treatment decisions and contributing to market growth. Histology and cytology provide essential information for tailoring treatment strategies based on a patient's unique disease characteristics, driving demand for these techniques.

Key Market Challenges

Technological Complexity and Costs

Advanced histology and cytology technologies often require significant investments in equipment, software, and training, which can pose barriers for institutions with limited resources. Maintenance costs and integration challenges with existing systems can also hinder technology adoption.

Laboratory Workforce Shortages

A shortage of skilled laboratory professionals can lead to delays in diagnosing and reporting test results, impacting patient care and innovation. Workforce shortages can limit the capacity for research, development, and the adoption of new technologies.

Key Market Trends

Liquid Biopsies and Circulating Biomarkers

The emergence of liquid biopsies, which analyze biomarkers in bodily fluids, contributes to the demand for histology and cytology services. These biopsies enable early disease detection and require validation through traditional histological and cytological methods.

Multi-Omics Approaches

Multi-omics approaches that study diseases at multiple levels simultaneously enhance the demand for histology and cytology. These techniques provide comprehensive insights into disease mechanisms, and histology and cytology validate findings from multi-omics data.

Segmental Insights

Type of Examination

The cytology segment is expected to witness substantial growth due to its role in early disease detection. Techniques like Pap smears and fine-needle aspirations aid in identifying abnormal cellular changes, leading to timely interventions and improved patient outcomes.

Application

The Drug Discovery & Designing segment dominates the market as histology and cytology are crucial for validating drug targets, assessing drug safety, and enabling personalized medicine. These techniques provide insights into molecular interactions and tissue-specific effects.

Regional Insights

North America leads the market due to its advanced healthcare systems, research institutions, and regulatory framework. The concentration of research efforts and a clear regulatory environment encourage innovation and technology adoption, driving market growth.

Key Market Players

  • Hologic, Inc.
  • F Hoffmann-La Roche AG.
  • Abbott Laboratories Inc.
  • Becton Dickinson & Co.
  • Danaher Corporation.
  • Merck KGaA.
  • Thermo Fisher Scientific, Inc.
  • Sysmex Corporation.
  • Trivitron Healthcare.
  • Koninklijke Philips N.V.

Report Scope:

In this report, the Global Histology and Cytology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

Histology and Cytology Market, By Type of Examination:

  • Histology
  • Cytology

Histology and Cytology Market, By Product:

  • Instruments and Analysis Software System
  • Consumable and Reagents

Histology and Cytology Market, By Application:

  • Drug Discovery & Designing
  • Clinical Diagnostics
  • Research

Histology and Cytology Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Histology and Cytology Market.

Available Customizations:

  • Global Histology and Cytology market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Histology and Cytology Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type Of Examination (Histology, Cytology)
    • 5.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
    • 5.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Type of Examination
    • 5.3.2 By Product
    • 5.3.3 By Application
    • 5.3.4 By Region

6. North America Histology and Cytology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type Of Examination (Histology, Cytology)
    • 6.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
    • 6.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Histology and Cytology Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type of Examination
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Histology and Cytology Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type of Examination
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Histology and Cytology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type of Examination
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Application

7. Europe Histology and Cytology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type Of Examination (Histology, Cytology)
    • 7.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
    • 7.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Histology and Cytology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Examination
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Application
    • 7.3.2. Germany Histology and Cytology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Examination
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Histology and Cytology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Examination
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Histology and Cytology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of Examination
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Histology and Cytology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of Examination
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Application

8. Asia-Pacific Histology and Cytology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type Of Examination (Histology, Cytology)
    • 8.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
    • 8.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Histology and Cytology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Examination
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Application
    • 8.3.2. India Histology and Cytology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Examination
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Histology and Cytology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Examination
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Histology and Cytology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Examination
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Histology and Cytology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Examination
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Application

9. South America Histology and Cytology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type Of Examination (Histology, Cytology)
    • 9.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
    • 9.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Histology and Cytology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Examination
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Application
    • 9.3.2. Argentina Histology and Cytology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Examination
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Application
    • 9.3.3. Colombia Histology and Cytology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Examination
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Application

10. Middle East and Africa Histology and Cytology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type Of Examination (Histology, Cytology)
    • 10.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
    • 10.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Histology and Cytology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Examination
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Application
    • 10.3.2. Saudi Arabia Histology and Cytology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Drug Type
        • 10.3.2.2.2. By Type of Examination
        • 10.3.2.2.3. By Product
        • 10.3.2.2.4. By Application
    • 10.3.3. UAE Histology and Cytology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Examination
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Histology And Cytology Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 Hologic, Inc.
    • 15.6.2 F Hoffmann-La Roche AG.
    • 15.6.3 Abbott Laboratories Inc.
    • 15.6.4 Becton Dickinson & Co.
    • 15.6.5 Danaher Corporation.
    • 15.6.6 Merck KGaA.
    • 15.6.7 Thermo Fisher Scientific, Inc.
    • 15.6.8 Sysmex Corporation.
    • 15.6.9 Trivitron Healthcare.
    • 15.6.10 Koninklijke Philips N.V.

16. Strategic Recommendations